Related Experiment Video
Updated: May 17, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Data imbalance in drug response prediction: multi-objective optimization approach in deep learning setting
Oleksandr Narykov1, Yitan Zhu1, Thomas Brettin1
1Computing, Environment and Life Sciences, Argonne National Laboratory, 9700 S Cass Ave, Lemont, IL 60439, United States.
Abstract:
Drug response prediction (DRP) methods tackle the complex task of associating the effectiveness of small molecules with the specific genetic makeup of the patient. Anti-cancer DRP is a particularly challenging task requiring costly experiments as underlying pathogenic mechanisms are broad and associated with multiple genomic pathways. The scientific community has exerted significant efforts to generate public drug screening datasets, giving a path to various machine learning models that attempt to reason over complex data space of small compounds and biological characteristics of tumors. However, the data depth is still lacking compared to application domains like computer vision or natural language processing domains, limiting current learning capabilities. To combat this issue and improves the generalizability of the DRP models, we are exploring strategies that explicitly address the imbalance in the DRP datasets. We reframe the problem as a multi-objective optimization across multiple drugs to maximize deep learning model performance. We implement this approach by constructing Multi-Objective Optimization Regularized by Loss Entropy loss function and plugging it into a Deep Learning model. We demonstrate the utility of proposed drug discovery methods and make suggestions for further potential application of the work to achieve desirable outcomes in the healthcare field.
Insights
This study introduces a novel multi-objective optimization approach to improve anti-cancer drug response prediction (DRP) models. By addressing data imbalance, the method enhances deep learning model performance for personalized medicine and drug discovery.
Area of Science:
- Computational biology
- Machine learning in oncology
- Drug discovery and development
Background:
- Drug response prediction (DRP) links patient genetics to drug effectiveness, crucial for personalized cancer therapy.
- Anti-cancer DRP is complex due to broad pathogenic mechanisms and limited data depth compared to other AI domains.
- Existing DRP models struggle with data imbalance, hindering generalizability and clinical application.
Purpose of the Study:
- To develop strategies addressing data imbalance in DRP datasets.
- To enhance the generalizability and performance of deep learning-based DRP models.
- To reframe DRP as a multi-objective optimization problem across multiple drugs.
Main Methods:
- Implemented a Multi-Objective Optimization Regularized by Loss Entropy (MOORLE) loss function.
- Integrated the MOORLE loss function into a deep learning model architecture.
- Evaluated the approach on anti-cancer drug screening datasets.
Main Results:
- Demonstrated improved performance of DRP models by addressing data imbalance.
- The multi-objective optimization strategy enhanced model generalizability.
- The proposed method shows utility for advancing drug discovery and personalized medicine.
Conclusions:
- The MOORLE approach effectively tackles data imbalance in DRP.
- This strategy enhances deep learning model performance for anti-cancer drug response prediction.
- The work offers a pathway for improved drug discovery and healthcare outcomes.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis of Population Pharmacokinetic Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...